Intravacc, a world leading contract development and manufacturing organization (CDMO) of preventive and therapeutic vaccines and the German Center for Neurogenerative Diseases (DZNE), have...
NRx Pharmaceuticals, a clinical-stage, biopharmaceutical company has received scientific evidence from the Israel Institute for Biological Research (IIBR) that the BriLife® vaccine may produce...
Integrated Viral Protection (IVP), is demonstrating its scientifically proven technology in Las Vegas at CES 2022, announcing the release of its new Personal Air...
Parenteral vial shortages have persisted since the first COVID-19 vaccines started being administered in late 2020, according to a new Freedonia Group analysis.
Also Read:...
The Phase 2 trial will evaluate SCB-2019 (CpG 1018/Alum) as a booster dose in individuals previously vaccinated with CoronaVac or recombinant Covid-19 vaccine (AstraZeneca/Fiocruz)
Also...
